Agenus reported $18.1M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.3B 174M
Agenus AGEN:US USD 18.1M 809K
Amgen AMGN:US USD 1.29B 40M
AstraZeneca AZN:LN USD 3.35B 280M
Bristol Myers Squibb BMY:US USD 1.93B 147M
Celldex Therapeutics CLDX:US USD 6.53M 623K
CSL CSL:AU USD 900.7M 152.7M
Dynavax Technologies DVAX:US USD 32.04M 3.69M
Eli Lilly And LLY:US USD 1.61B 10.9M
Genocea Biosciences GNCA:US USD 3.6M 473K
Gilead Sciences GILD:US USD 1.21B 144M
Glaxosmithkline GSK:US GBP 1.97B 13M
GlaxoSmithKline GSK:LN GBP 1.97B 13M
Immunogen IMGN:US USD 33.62M 9.83M
Intrexon XON:US USD 10.14M 2.53M
Jiangsu Hengrui Me. 600276:CH CNY 2.37B 415.39M
Johnson & Johnson JNJ:US USD 6.09B 137M
Karyopharm Therapeutics KPTI:US USD 34.64M 2.69M
Macrogenics MGNX:US USD 15.35M 1.69M
Merck MRK:GR EUR 1.55B 26M
Merk MRK:US USD 2.47B 13M
Northwest Biotherapeutics NWBO:US USD 8.13M 199K
Novartis NOVN:VX USD 3.4B 185M
Novavax NVAX:US USD 122.88M 14.72M
Pfizer PFE:US USD 3.54B 345M
Regeneron Pharmaceuticals REGN:US USD 529.1M 52.8M
Rigel Pharmaceuticals RIGL:US USD 25.9M 1.08M
Sangamo Biosciences SGMO:US USD 16.24M 1.14M
Veracyte VCYT:US USD 42.73M 2.77M
YTE INCY:US USD 266.46M 13.18M